ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,871.56
1.39%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.965
-0.01%
Brent Oil
81.965
0.81%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Dermata Therapeutics Inc (DRMA)

  7. Dermata Therapeutics Inc (DRMA) ニュース

DRMA

Dermata Therapeutics (DRMA)

Dermata Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:DRMA
日付受信時刻ニュースソース見出しコード企業名
2024/01/1306 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2023/12/1814 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
2023/12/1607 : 00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DRMADermata Therapeutics Inc
2023/12/0907 : 29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRMADermata Therapeutics Inc
2023/12/0806 : 05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
2023/11/3007 : 16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:DRMADermata Therapeutics Inc
2023/11/1006 : 09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
2023/11/1006 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2023/09/1505 : 32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRMADermata Therapeutics Inc
2023/08/1105 : 18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2023/08/1105 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
2023/08/0405 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2023/07/2813 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
2023/07/2805 : 50Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:DRMADermata Therapeutics Inc
2023/07/1222 : 02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DRMADermata Therapeutics Inc
2023/07/0805 : 21Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
2023/06/2405 : 29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DRMADermata Therapeutics Inc
2023/06/2405 : 19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DRMADermata Therapeutics Inc
2023/06/1306 : 28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DRMADermata Therapeutics Inc
2023/05/2506 : 14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
2023/05/1205 : 08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DRMADermata Therapeutics Inc
2023/05/1205 : 08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
2023/04/0105 : 11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
2023/03/3105 : 08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
2023/03/2119 : 01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DRMADermata Therapeutics Inc
2023/03/2105 : 37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DRMA

最近閲覧した銘柄

AMEX
XLF
Financial Select Sector
USOTC
BASFY
BASF (QX)
NYSE
BAC
Bank of America
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
NYSE
XOM
Exxon Mobil
FX
USDJPY
US Dollar vs Yen
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
FX
USDEUR
US Dollar vs Euro
CCOM
US500
US 500
SPI
SP500
S&P 500
NYSE
CVX
Chevron
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有